Mesa Laboratories (MLAB) Stock Forecast, Price & News

0 equities research analysts have issued 12-month price objectives for Mesa Laboratories' shares. Their MLAB share price forecasts range from $166.00 to $166.00. On average, they predict the company's stock price to reach $166.00 in the next year. This suggests a possible upside of 26.4% from the stock's current price.
View analysts price targets for MLAB or view top-rated stocks among Wall Street analysts.

Mesa Laboratories' stock was trading at $166.21 at the start of the year. Since then, MLAB shares have decreased by 21.0% and is now trading at $131.36.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023.
View our MLAB earnings forecast.

Mesa Laboratories, Inc. (NASDAQ:MLAB) released its quarterly earnings results on Monday, May, 31st. The medical instruments supplier reported $0.74 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.91 by $0.17. The medical instruments supplier had revenue of $37.96 million for the quarter, compared to analyst estimates of $34.92 million. Mesa Laboratories had a trailing twelve-month return on equity of 8.40% and a net margin of 0.42%.

Mesa Laboratories declared a quarterly dividend on Monday, April 3rd. Shareholders of record on Wednesday, May 31st will be paid a dividend of $0.16 per share on Thursday, June 15th. This represents a $0.64 annualized dividend and a dividend yield of 0.49%. The ex-dividend date is Tuesday, May 30th.
Read our dividend analysis for MLAB.

ETFs with the largest weight of Mesa Laboratories (NASDAQ:MLAB) stock in their portfolio include MFAM Small-Cap Growth ETF (MFMS), Motley Fool Small-Cap Growth ETF (TMFS), SPDR S&P Health Care Equipment ETF (XHE), Invesco S&P SmallCap Health Care ETF (PSCH), Principal Healthcare Innovators ETF (BTEC), iShares U.S. Medical Devices ETF (IHI),

Mesa Laboratories (NASDAQ:MLAB) pays an annual dividend of $0.64 per share and currently has a dividend yield of 0.49%. The dividend payout ratio is 400.03%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, MLAB will have a dividend payout ratio of 6.91% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for MLAB.

5 employees have rated Mesa Laboratories Chief Executive Officer Gary Owens on Glassdoor.com. Gary Owens has an approval rating of 51% among the company's employees. This puts Gary Owens in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Mesa Laboratories investors own include NVIDIA (NVDA), Verizon Communications (VZ), Intel (INTC), Alibaba Group (BABA), Altria Group (MO), Micron Technology (MU), Exxon Mobil (XOM), AbbVie (ABBV), Advanced Micro Devices (AMD) and Becton, Dickinson and (BDX).

Mesa Laboratories trades on the NASDAQ under the ticker symbol "MLAB."

Mesa Laboratories' stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (16.16%), Conestoga Capital Advisors LLC (10.81%), Ranger Investment Management L.P. (4.19%), State Street Corp (4.08%), Principal Financial Group Inc. (3.06%) and Royce & Associates LP (2.95%). Insiders that own company stock include Brian David Archbold, David M Kelly, Evan Guillemin, Gary M Owens, Gregory Dinoia, John Bradley Schmieder, John James Sullivan, John Sakys and Shannon Hall.
View institutional ownership trends.

Shares of MLAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of MLAB stock can currently be purchased for approximately $131.36.

Mesa Laboratories (NASDAQ:MLAB) has a market capitalization of $705.40 million and generates $219.08 million in revenue each year. The medical instruments supplier earns $930,000.00 in net income (profit) each year or $0.16 on an earnings per share basis.

The company employs 506 workers across the globe.

Mesa Laboratories' mailing address is 12100 W 6TH AVE, LAKEWOOD CO, 80228. The official website for the company is www.mesalabs.com. The medical instruments supplier can be reached via phone at (303) 987-8000, via email at investorrelations@mesalabs.com, or via fax at 303-987-8989.